BioAge’s Hopes For Combo Obesity Drug Dim Due To Liver Safety

Phase II Trial, Designed With Lilly, Cancelled

 
• By Jessica Merrill
  
(Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Alimentary/Metabolic

More from R&D